ICOTINIB: 41 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
41
Total FAERS Reports
4 (9.8%)
Deaths Reported
4
Hospitalizations
41
As Primary/Secondary Suspect
1
Disabilities
First Report: 2014 · Latest Report: 20240816
What Are the Most Common ICOTINIB Side Effects?
#1 Most Reported
Rash
14 reports (34.1%)
#2 Most Reported
Hypertension
12 reports (29.3%)
#3 Most Reported
Malignant neoplasm progression
10 reports (24.4%)
All ICOTINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 14 | 34.2% | 1 | 1 |
| Hypertension | 12 | 29.3% | 0 | 0 |
| Diarrhoea | 10 | 24.4% | 0 | 0 |
| Malignant neoplasm progression | 10 | 24.4% | 2 | 2 |
| Fatigue | 9 | 22.0% | 1 | 0 |
| Bone marrow failure | 7 | 17.1% | 0 | 1 |
| Proteinuria | 7 | 17.1% | 0 | 0 |
| Vomiting | 7 | 17.1% | 2 | 0 |
| Disease progression | 6 | 14.6% | 0 | 0 |
| Haemorrhage | 6 | 14.6% | 0 | 0 |
| Nausea | 6 | 14.6% | 2 | 0 |
| Anaemia | 5 | 12.2% | 0 | 0 |
| Leukopenia | 5 | 12.2% | 0 | 0 |
| Liver injury | 5 | 12.2% | 0 | 1 |
Who Reports ICOTINIB Side Effects? Age & Gender Data
Gender: 62.5% female, 37.5% male. Average age: 61.7 years. Most reports from: CN. View detailed demographics →
Is ICOTINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 0 |
| 2015 | 1 | 1 | 0 |
| 2017 | 1 | 0 | 0 |
| 2018 | 4 | 1 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 1 |
What Is ICOTINIB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer | 15 |
| Lung adenocarcinoma | 8 |
Official FDA Label for ICOTINIB
Official prescribing information from the FDA-approved drug label.